References
Orlowski JP, Hanhan UA, Fiallos MR. Is aspirin a cause of Reye’s syndrome? A case against. Drug Saf 2002; 25(4): 225–31
Jack DB. One hundred years of aspirin. Lancet 1997; 350(9075): 437–9
Mackowiak PA. Brief history of antipyretic therapy. Clin Infec Dis 2000; 31Suppl. 5: S154–6
Gerhardt CF. Liebig’s Annalen 1853; 87: 149
Van Arman CG, Armstrong DA, Kim DH. Antipyretics. Pharmacol Ther 1985; 29(1): 1–48
The discovery of aspirin. Nurs Stand 1999; 13(21): 33–4
Sneader W. The discovery of aspirin: a reappraisal. BMJ 2000; 321(7276): 1591–4
Spooner JB, Harvey JG. The history and usage of paracetamol. J Intern Med Res 1976; 4(4): 1–6
Roberts LJ, Morrow JD. Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Limbird LE, editors. Goodman & Gilman’s the pharmacological basis of therapeutics. 10 ed. New York; McGraw-Hill, 2001: 687–732
Cahn A, Hepp P. Das Antifebrin, ein neues Fiebermittel. Centrabl Klin Med 1886; 7: 561–4
von Mering J. Beiträge zur Kenntniss der Antipyretica. Therapeutische Monatsschrift 1893; 7: 577–87
Clissold SP. Paracetamol and phenacetin. Drugs 1986; 32Suppl. 4: 46–59
Brodie BB, Axelrod J. The fate of acetophenetidin (phenacetin) in man and methods for the estimation of acetophenetidin and itsmetabolites in biological material. J Pharmacol Exper Ther 1949; 97: 58–67
Aronoff DM, Neilson EG. Antipyretics: mechanisms of action and clinical use in fever suppression. Am J Med 2001; 111(4): 304–15
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aronoff, D.M. Aspirin and Reye’s Syndrome. Drug-Safety 25, 751 (2002). https://doi.org/10.2165/00002018-200225100-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-200225100-00007